| BMY |
Bristol-Myers Squibb Company |
116.28B |
9.01% |
|
|
|
|
|
57.33 |
1.83% |
28.90% |
41.38% |
|---|
| PFE |
Pfizer Inc. |
149.38B |
7.07% |
|
|
|
|
|
26.36 |
2.29% |
26.92% |
45.78% |
|---|
| ABBV |
AbbVie Inc. |
310.27B |
6.98% |
|
|
|
|
|
175.58 |
2.37% |
25.31% |
55.38% |
|---|
| JNJ |
Johnson & Johnson |
347.83B |
6.91% |
|
|
|
|
|
144.47 |
0.62% |
19.93% |
50.22% |
|---|
| MRK |
Merck & Co., Inc. |
248.03B |
6.57% |
|
|
|
|
|
98.05 |
-1.48% |
25.78% |
55.19% |
|---|
| GILD |
Gilead Sciences, Inc. |
115.37B |
4.54% |
|
|
|
|
|
92.57 |
1.62% |
36.85% |
46.92% |
|---|
| CAH |
Cardinal Health, Inc. |
28.63B |
4.07% |
|
|
|
|
|
118.28 |
1.09% |
26.74% |
42.37% |
|---|
| VTRS |
Viatris Inc. |
14.94B |
4.02% |
|
|
|
|
|
12.52 |
3.22% |
30.30% |
30.97% |
|---|
| UTHR |
United Therapeutics Corporation |
16.05B |
3.76% |
|
|
|
|
|
359.58 |
-0.16% |
N/A |
N/A |
|---|
| ZTS |
Zoetis Inc. |
74.37B |
3.60% |
|
|
|
|
|
164.84 |
0.81% |
25.60% |
15.37% |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
7.43B |
3.53% |
|
|
|
|
|
122.97 |
0.10% |
32.47% |
28.35% |
|---|
| LLY |
Eli Lilly and Company |
728.85B |
3.15% |
|
|
|
|
|
767.76 |
1.35% |
37.07% |
38.72% |
|---|
| AMGN |
Amgen Inc. |
141.58B |
3.07% |
|
|
|
|
|
263.38 |
0.84% |
25.97% |
20.88% |
|---|
| BIIB |
Biogen Inc. |
21.34B |
2.84% |
|
|
|
|
|
146.47 |
-0.62% |
33.95% |
70.80% |
|---|
| OGN |
Organon & Co. |
3.75B |
2.40% |
|
|
|
|
|
14.58 |
0.97% |
48.12% |
52.73% |
|---|
| CRL |
Charles River Laboratories International... |
9.50B |
2.40% |
|
|
|
|
|
185.77 |
1.99% |
39.83% |
47.29% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
75.85B |
2.39% |
|
|
|
|
|
701.85 |
-0.90% |
34.78% |
72.04% |
|---|
| MEDP |
Medpace Holdings, Inc. |
10.48B |
1.85% |
|
|
|
|
|
337.28 |
0.64% |
40.42% |
31.72% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
13.71B |
1.60% |
|
|
|
|
|
135.42 |
0.34% |
36.61% |
2.44% |
|---|
| ELAN |
Elanco Animal Health Incorporated |
5.75B |
1.60% |
|
|
|
|
|
11.63 |
-1.61% |
59.61% |
51.77% |
|---|
| ALKS |
Alkermes plc |
4.81B |
1.18% |
|
|
|
|
|
29.71 |
-0.87% |
46.26% |
66.15% |
|---|
| EXEL |
Exelixis, Inc. |
9.51B |
1.12% |
|
|
|
|
|
33.29 |
-1.16% |
38.11% |
33.80% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
5.97B |
1.08% |
|
|
|
|
|
46.96 |
-0.76% |
45.48% |
38.93% |
|---|
| PBH |
Prestige Consumer Healthcare Inc. |
3.89B |
0.97% |
|
|
|
|
|
78.72 |
0.08% |
13.41% |
44.64% |
|---|
| PRGO |
Perrigo Company plc |
3.51B |
0.96% |
|
|
|
|
|
25.75 |
0.08% |
42.11% |
40.47% |
|---|
| CORT |
Corcept Therapeutics Incorporated |
5.39B |
0.82% |
|
|
|
|
|
51.40 |
0.49% |
64.03% |
29.52% |
|---|
| TGTX |
TG Therapeutics, Inc. |
5.01B |
0.73% |
|
|
|
|
|
32.20 |
4.04% |
85.53% |
58.29% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.47B |
0.70% |
|
|
|
|
|
41.49 |
4.93% |
68.97% |
27.99% |
|---|
| ITCI |
Intra-Cellular Therapies, Inc. |
8.85B |
0.65% |
|
|
|
|
|
83.45 |
-0.82% |
41.43% |
17.81% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
31.66B |
0.62% |
|
|
|
|
|
245.44 |
2.75% |
37.31% |
31.83% |
|---|
| ACLX |
Arcellx, Inc. |
4.08B |
0.60% |
|
|
|
|
|
75.54 |
0.44% |
59.95% |
42.57% |
|---|
| VCEL |
Vericel Corporation |
2.79B |
0.60% |
|
|
|
|
|
56.50 |
2.82% |
52.61% |
36.15% |
|---|
| TWST |
Twist Bioscience Corporation |
2.85B |
0.57% |
|
|
|
|
|
47.94 |
9.90% |
67.40% |
23.67% |
|---|
| INCY |
Incyte Corporation |
13.26B |
0.57% |
|
|
|
|
|
68.84 |
2.65% |
52.75% |
75.41% |
|---|
| ADMA |
ADMA Biologics, Inc. |
4.11B |
0.56% |
|
|
|
|
|
17.40 |
-2.79% |
68.48% |
16.62% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.81B |
0.56% |
|
|
|
|
|
16.87 |
0.84% |
53.83% |
32.25% |
|---|
| BPMC |
Blueprint Medicines Corporation |
5.73B |
0.53% |
|
|
|
|
|
90.14 |
1.36% |
56.46% |
30.27% |
|---|
| ROIV |
Roivant Sciences Ltd. |
8.42B |
0.53% |
|
|
|
|
|
11.57 |
0.61% |
45.10% |
54.92% |
|---|
| EXAS |
Exact Sciences Corporation |
10.99B |
0.51% |
|
|
|
|
|
59.40 |
5.86% |
56.47% |
43.25% |
|---|
| INSM |
Insmed Incorporated |
12.60B |
0.50% |
|
|
|
|
|
70.44 |
1.48% |
61.36% |
12.19% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
102.31B |
0.50% |
|
|
|
|
|
397.27 |
0.16% |
52.65% |
97.77% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
3.59B |
0.49% |
|
|
|
|
|
7.78 |
0.39% |
560.06% |
32.47% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
11.36B |
0.49% |
|
|
|
|
|
118.97 |
-0.42% |
41.48% |
17.53% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
2.63B |
0.44% |
|
|
|
|
|
40.66 |
3.88% |
67.80% |
52.06% |
|---|
| KRYS |
Krystal Biotech, Inc. |
4.74B |
0.44% |
|
|
|
|
|
164.83 |
2.49% |
56.31% |
46.00% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
12.51B |
0.44% |
|
|
|
|
|
65.66 |
1.02% |
36.49% |
36.43% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
5.63B |
0.42% |
|
|
|
|
|
35.63 |
0.11% |
47.85% |
72.37% |
|---|
| RNA |
Avidity Biosciences, Inc. |
3.80B |
0.38% |
|
|
|
|
|
31.82 |
2.48% |
62.95% |
21.24% |
|---|
| VKTX |
Viking Therapeutics, Inc. |
4.71B |
0.33% |
|
|
|
|
|
42.25 |
1.83% |
70.48% |
13.95% |
|---|
| MYGN |
Myriad Genetics, Inc. |
1.22B |
0.26% |
|
|
|
|
|
13.36 |
1.44% |
47.92% |
77.50% |
|---|
|
US Dollar |
|
0.13% |
|
|
|
|
|
|
|
|
|
|---|